These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18525386)

  • 1. Contemporary trends in cardiac rehabilitation in Germany: patient characteristics, drug treatment, and risk-factor management from 2000 to 2005.
    Bestehorn K; Wegscheider K; Völler H
    Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):312-8. PubMed ID: 18525386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of inpatient rehabilitation on cardiovascular risk factors in patients with coronary heart disease. PIN-Study Group].
    Völler H; Hahmann H; Gohlke H; Klein G; Rombeck B; Binting S; Willich SN
    Dtsch Med Wochenschr; 1999 Jul; 124(27):817-23. PubMed ID: 10432941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes of risk factors in patients with coronary heart disease after in-patient rehabilitation].
    Küpper-Nybelen J; Rothenbacher D; Hahmann H; Wüsten B; Brenner H
    Dtsch Med Wochenschr; 2003 Jul; 128(28-29):1525-30. PubMed ID: 12854061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Health promotion and inpatient rehabilitation. Long-term effects of education in patients with coronary heart disease].
    Baberg HT; Uzun D; de Zeeuw J; Sinclair R; Bojara W; Mügge A; Schubmann R
    Herz; 2005 Dec; 30(8):754-60. PubMed ID: 16331371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry.
    Gitt AK; Juenger C; Jannowitz C; Karmann B; Senges J; Bestehorn K
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):438-44. PubMed ID: 19369876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines database).
    Albert NM; Birtcher KK; Cannon CP; Goff DC; Mulgund J; Liang L; Fonarow GC
    Am J Cardiol; 2008 May; 101(9):1242-6. PubMed ID: 18435951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV; Frick KD; Wade A; Simko R; Burge R
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment patterns and risk factor control in patients with and without metabolic syndrome in cardiac rehabilitation.
    Gitt A; Jannowitz C; Karoff M; Karmann B; Horack M; Völler H
    Vasc Health Risk Manag; 2012; 8():265-74. PubMed ID: 22566748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug utilization of ezetimibe in rehabilitation centres: registry analysis of factors influencing prescription and effectiveness of treatment.
    Bestehorn K; Völler H; Benecke H; Renner H; Karmann B; Wegscheider K
    Curr Med Res Opin; 2006 Apr; 22(4):631-9. PubMed ID: 16684423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of optimized integrated management on long-term effectiveness of cardiologic rehabilitation].
    Gohlke H; Jarmatz H; Zaumseil J; Bestehorn K; Jansen C; Hasford J
    Dtsch Med Wochenschr; 2000 Dec; 125(48):1452-6. PubMed ID: 11153413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in risk factor control in Germany 1984-1998: high blood pressure and total cholesterol.
    Laaser U; Breckenkamp J
    Eur J Public Health; 2006 Apr; 16(2):217-22. PubMed ID: 16093306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term disease management of patients with coronary disease by cardiac rehabilitation program staff.
    Squires RW; Montero-Gomez A; Allison TG; Thomas RJ
    J Cardiopulm Rehabil Prev; 2008; 28(3):180-6; quiz 187-8. PubMed ID: 18496316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional variation in medication following coronary events in Germany.
    Müller-Nordhorn J; Kulig M; Binting S; Völler H; Krobot KJ; Willich SN
    Int J Cardiol; 2005 Jun; 102(1):47-53. PubMed ID: 15939098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vocational rehabilitation in German vocational retraining centres and results of Berufsförderungswerk Heidelberg gGmbH].
    Tews HP; Schreiber WK; Schott J
    Rehabilitation (Stuttg); 2003 Feb; 42(1):36-44. PubMed ID: 12560999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary heart disease and dyslipidemia: a cross-sectional evaluation of prevalence, current treatment, and clinical control in a large cohort of Spanish high-risk patients: the PRINCEPS study.
    de Rojas FD; De Frutos T; Ponte A; Chacón JM; Vitale GC;
    Prev Cardiol; 2009; 12(2):65-71. PubMed ID: 19476579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of cardiac rehabilitation program delivery models in patients at varying cardiac risk, reason for referral, and sex.
    Papadakis S; Reid RD; Coyle D; Beaton L; Angus D; Oldridge N
    Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):347-53. PubMed ID: 18525392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term risk factor management after inpatient cardiac rehabilitation by means of a structured post-care programme.
    Harb BM; Wonisch M; Brandt D; Müller R
    Eur J Cardiovasc Prev Rehabil; 2011 Dec; 18(6):843-9. PubMed ID: 21450590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    O'Connor CM; Abraham WT; Albert NM; Clare R; Gattis Stough W; Gheorghiade M; Greenberg BH; Yancy CW; Young JB; Fonarow GC
    Am Heart J; 2008 Oct; 156(4):662-73. PubMed ID: 18926148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of high-risk patients with hypertension and left ventricular hypertrophy in Germany: differences between cardiac specialists in the inpatient and outpatient setting.
    Völler H; Sonntag FJ; Thiery J; Wegscheider K; Luft FC; Bestehorn K
    BMC Public Health; 2006 Oct; 6():256. PubMed ID: 17052329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.